Higher titer of NY-ESO-1 antigen in PCa serum in comparison to BPH and DC demonstrates that this antigen which is known to generate autoantibody response in many human cancers, could be a part of diagnostic antigen biomarker panel for PCa. Here, CTAG1A is linked to posterior cortical atrophy.